Fig. 1: Kaplan–Meier survival curve for all patients after propensity score matching.
From: Prognostic difference between early breast cancer patients with HER2 low and HER2 zero status
A Overall survival, (B) recurrence-free survival, (C) locoregional-free survival, (D) distant recurrence-free survival. Red line: patients with HER2-low expression, blue line: patients with HER2-zero expression.
